Outcomes of Patients Undergoing Combined Heart–Kidney Transplantation With or Without Prior Ventricular Assist Device
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2023.04.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Maria Currie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California. Electronic address: mecurrie@stanford.edu. Hauptthemen laut MEDLINE: Kidney Transplantation, Heart-Assist Devices, Heart Transplantation, Heart Failure. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Both combined heart-kidney transplantation and ventricular assist devices (VADs) pose significant challenges, including sensitization, immunosuppressive treatment, and infrastructure demands. Despite these challenges, we hypothesized that the recipients of combined heart-kidney transplants with and without VADs would have equivalent survival. We aimed to compare the survival of heart-kidney transplant recipients with and without prior VAD placement. METHODS: We retrospectively analyzed all patients enrolled in the United Network for Organ Sharing database who underwent heart-kidney transplants. We created a matched cohort of patients undergoing heart-kidney transplantation with or without prior VAD using 1:1 nearest propensity-score matching with preoperative variables. RESULTS: In the propensity-matched cohort, 399 patients underwent heart-kidney transplantation with prior VAD, and 399 underwent heart-kidney transplantation without prior VAD. The estimated survival of heart--kidney recipients with prior VAD was 84.8% at one year, 81.2% at 3 years, and 75.3% at 5 years. The estimated survival of heart-kidney recipients without prior VAD was 86.8.7% at one year, 84.0% at 3 years, and 78.8% at 5 years. There was no statistically significant difference in the survival of heart-kidney transplant recipients with or without prior VAD at one year (P = .42; Figure 2), 3 years (P = .34), or 5 years (P = .30). CONCLUSION: Despite the increased challenge of heart-kidney transplantation in recipients with prior VAD, we demonstrated that these patients have similar survival to those who underwent heart-kidney transplantation without previous VAD placement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California. Electronic address: mecurrie@stanford.edu.
- Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Zitieren
APA
Currie, M., Leipzig, M., Kaghazchi, A., Zhu, Y., Shudo, Y., & Woo, Y. J. (2023). Outcomes of Patients Undergoing Combined Heart–Kidney Transplantation With or Without Prior Ventricular Assist Device. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.04.037
Vancouver
Currie M, Leipzig M, Kaghazchi A, Zhu Y, Shudo Y, Woo YJ. Outcomes of Patients Undergoing Combined Heart–Kidney Transplantation With or Without Prior Ventricular Assist Device. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.04.037
BibTeX
@article{Currie2023,
author = {Currie, Maria and Leipzig, Matthew and Kaghazchi, Aydin and Zhu, Yuanjia and Shudo, Yasuhiro and Woo, Y Joseph},
title = {Outcomes of Patients Undergoing Combined Heart–Kidney Transplantation With or Without Prior Ventricular Assist Device},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2023.04.037}
}
EUVIMED